Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
4
×
clinical trials
4
×
life sciences
national blog main
national top stories
roche
4
×
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
deals
fda
larotrectinib
loxo oncology
merck
new england journal of medicine
president trump
sanofi
What
drug
4
×
cancer
new
roundup
targets
advantages
ahead
ambien
american
annual
approved
asco
attendees
attention
bar
bio
biotech
brings
camp’s
cash
chicago
city
clinical
combinations
community’s
days
deeper
despite
dna
expanding
expect
family
fda
fingerprint
focus
gamble
genetic
going
hardest
hit
Language
unset
Current search:
roche
×
drug
×
cancer
×
" clinical trials "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More